ClinConnect ClinConnect Logo
Search / Trial NCT06586749

Effect of Nurse-Led Education and Tele-Interventions on Reducing Surgical Site Infections in Patients After Coronary Artery Bypass Surgery: a Clinical Trial

Launched by HELLENIC MEDITERRANEAN UNIVERSITY · Sep 4, 2024

Trial Information

Current as of July 01, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying whether education led by nurses and follow-up phone support can help prevent infections in patients after heart surgery known as coronary artery bypass grafting (CABG). The researchers want to find out if teaching patients about wound care from nurses can lower the chance of infections and if adding phone check-ins can make an even bigger difference compared to just standard care.

To participate, you need to be at least 18 years old and have had CABG surgery. It's important that you can read and write in Greek and have access to a smartphone. If you join the trial, you will be placed in one of three groups: one will receive standard care, another will get nurse-led education, and the last group will receive both education and phone support. Throughout the study, you'll have regular follow-ups to check on your recovery and monitor for any infections. This trial is currently recruiting participants, and it aims to help improve recovery for heart surgery patients by reducing the risk of infections.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Age ≥ 18 years
  • Patients who have undergone CABG with median sternotomy
  • Proficiency in reading and writing in Greek
  • Patients who provide written informed consent for participation in the study
  • Patients who have access to a mobile phone and know how to use it
  • Patients without difficulties in vision, speech, or hearing
  • Patients at intermediate or high risk for developing surgical site infections, based on their scores in the risk stratification models described below
  • Exclusion Criteria:
  • History of psychiatric illness, recent history of alcohol and/or substance abuse, dementia, and Alzheimer's disease
  • Presence of an active infection within 2 weeks prior to the surgical procedure
  • Preoperative hospitalization \> 2 days
  • Concurrent surgery on the aorta or heart valves
  • Urgent or emergency nature of the surgical procedure
  • Re-sternotomy aimed at surgical re-exploration of bleeding or implementation of cardiopulmonary resuscitation (CPR) in cases of cardiac arrest
  • Patients in whom the sternum has not been closed after the completion of the surgical procedure and who are transferred to the cardiothoracic unit without sternum closure
  • Active endocarditis
  • Life expectancy \< 6 months
  • Lack of a smartphone

About Hellenic Mediterranean University

Hellenic Mediterranean University (HMU) is a distinguished academic institution based in Greece, dedicated to advancing education, research, and innovation in the fields of health and medicine. As a clinical trial sponsor, HMU leverages its extensive expertise in biomedical research to facilitate the development of new therapies and interventions aimed at improving patient outcomes. The university is committed to upholding the highest ethical standards and regulatory compliance throughout the research process, fostering collaboration among multidisciplinary teams, and contributing to the global scientific community through impactful clinical studies.

Locations

Heraklion, Crete, Greece

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported